Thrombin generation and clot formation in methylene blue–treated plasma and cryoprecipitate
- 20 March 2009
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 49 (4) , 696-703
Abstract
Methylene blue (MB) treatment of plasma is known to reduce the activity of clotting factors, but its effect on thrombin generation and clot formation is not well documented. Individual clotting factors and inhibitors and global tests of thrombin generation and clot formation using rotational thrombelastometry (ROTEM) were assessed in a paired study of standard or MB plasma and cryoprecipitate (n = 20 each). MB treatment resulted in a 10 percent reduction in endogenous thrombin potential and 30 percent decrease in peak thrombin as well as the expected 20 to 35 percent loss of Factor (F)VIII, fibrinogen, and FXI activity. MB treatment had no effect on the rate of clot formation and increased the clot firmness by 20 percent as assessed by ROTEM. There were minimal further changes in either coagulation factor levels or thrombin generation when thawed plasma was stored for an additional 24 hours. FVIII and fibrinogen content of MB cryoprecipitate was reduced by 30 and 40 percent, respectively, but this was not associated with altered clot time or rate of clot formation by ROTEM and only an 8 percent decrease in clot firmness. It is concluded that MB treatment is associated with a reduction in the thrombin-generating capacity of plasma, but has very little effect on the strength of clot formation as assessed by thrombelastometry. The thrombin-generating capacity of standard and MB plasma is relatively unaltered by subsequent storage of thawed plasma at 4 degrees C for 24 hours.Keywords
This publication has 21 references indexed in Scilit:
- Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas®) and a development product (Uniplas®)Transfusion and Apheresis Science, 2007
- Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalenTransfusion, 2007
- Coagulation parameters of thawed fresh‐frozen plasma during storage at different temperaturesTransfusion Medicine, 2007
- Thrombelastography/thromboelastometryClinical and Laboratory Haematology, 2005
- Occurrence of cold activation of transfusion plasma during storage at +4 °CVox Sanguinis, 2005
- Methylene blue‐treated fresh‐frozen plasma: what is its contribution to blood safety?Transfusion, 2003
- The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulabilityPathophysiology of Haemostasis and Thrombosis, 2002
- Role of Phosphatidylethanolamine in Assembly and Function of the Factor IXa−Factor VIIIa Complex on Membrane SurfacesBiochemistry, 2000
- The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single‐donor fresh‐frozen plasmaTransfusion, 1994
- Stability of Factors V and VIII in Thawed Fresh Frozen Plasma UnitsTransfusion, 1980